 | • レポートコード：QYR2104Z3309 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、カポジ肉腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（古典的、風土病、免疫抑制療法、伝染性）、用途別市場規模（病院、がん研究機関、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・カポジ肉腫の市場動向 ・企業の競争状況、市場シェア ・カポジ肉腫の種類別市場規模（古典的、風土病、免疫抑制療法、伝染性） ・カポジ肉腫の用途別市場規模（病院、がん研究機関、クリニック） ・カポジ肉腫の北米市場規模2016-2027（アメリカ、カナダ） ・カポジ肉腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・カポジ肉腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・カポジ肉腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・カポジ肉腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aphios、Bristol Myers Squibb、Cytori Therapeutics、CytRx、Eli Lilly and Company、GlaxoSmithKline、Roche、Johnson and Johnson、Merck、Pfizer） ・結論 |
Kaposi’s sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised.
Four sub-types are described: classic, endemic, immunosuppresion therapy-related, and epidemic. Classic KS tends to affect older men, be slow growing, and affect the legs. Endemic KS occurs in young adult males in Africa and can be more aggressive. Immunosuppresion therapy-related KS generally occurs in people following organ transplantation and mostly affects the skin. Epidemic KS occurs in people with AIDS and many parts of the body can be affected. The diagnosis is by tissue biopsy while the extent of disease may be determined by medical imaging.
Market Analysis and Insights: Global Kaposi Sarcoma Market
The global Kaposi Sarcoma market size is projected to reach US$ 119.1 million by 2026, from US$ 105 million in 2019, at a CAGR of 1.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kaposi Sarcoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kaposi Sarcoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kaposi Sarcoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kaposi Sarcoma market.
Global Kaposi Sarcoma Scope and Market Size
Kaposi Sarcoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kaposi Sarcoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Classic
Endemic
Immunosuppresion Therapy-Related
Epidemic
Segment by Application
Hospital
Cancer Research Institution
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aphios
Bristol Myers Squibb
Cytori Therapeutics
CytRx
Eli Lilly and Company
GlaxoSmithKline
Roche
Johnson and Johnson
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kaposi Sarcoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Classic
1.2.3 Endemic
1.2.4 Immunosuppresion Therapy-Related
1.2.5 Epidemic
1.3 Market by Application
1.3.1 Global Kaposi Sarcoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Cancer Research Institution
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kaposi Sarcoma Market Perspective (2016-2027)
2.2 Kaposi Sarcoma Growth Trends by Regions
2.2.1 Kaposi Sarcoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kaposi Sarcoma Historic Market Share by Regions (2016-2021)
2.2.3 Kaposi Sarcoma Forecasted Market Size by Regions (2022-2027)
2.3 Kaposi Sarcoma Industry Dynamic
2.3.1 Kaposi Sarcoma Market Trends
2.3.2 Kaposi Sarcoma Market Drivers
2.3.3 Kaposi Sarcoma Market Challenges
2.3.4 Kaposi Sarcoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kaposi Sarcoma Players by Revenue
3.1.1 Global Top Kaposi Sarcoma Players by Revenue (2016-2021)
3.1.2 Global Kaposi Sarcoma Revenue Market Share by Players (2016-2021)
3.2 Global Kaposi Sarcoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kaposi Sarcoma Revenue
3.4 Global Kaposi Sarcoma Market Concentration Ratio
3.4.1 Global Kaposi Sarcoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kaposi Sarcoma Revenue in 2020
3.5 Kaposi Sarcoma Key Players Head office and Area Served
3.6 Key Players Kaposi Sarcoma Product Solution and Service
3.7 Date of Enter into Kaposi Sarcoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kaposi Sarcoma Breakdown Data by Type
4.1 Global Kaposi Sarcoma Historic Market Size by Type (2016-2021)
4.2 Global Kaposi Sarcoma Forecasted Market Size by Type (2022-2027)
5 Kaposi Sarcoma Breakdown Data by Application
5.1 Global Kaposi Sarcoma Historic Market Size by Application (2016-2021)
5.2 Global Kaposi Sarcoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Kaposi Sarcoma Market Size (2016-2027)
6.2 North America Kaposi Sarcoma Market Size by Type
6.2.1 North America Kaposi Sarcoma Market Size by Type (2016-2021)
6.2.2 North America Kaposi Sarcoma Market Size by Type (2022-2027)
6.2.3 North America Kaposi Sarcoma Market Size by Type (2016-2027)
6.3 North America Kaposi Sarcoma Market Size by Application
6.3.1 North America Kaposi Sarcoma Market Size by Application (2016-2021)
6.3.2 North America Kaposi Sarcoma Market Size by Application (2022-2027)
6.3.3 North America Kaposi Sarcoma Market Size by Application (2016-2027)
6.4 North America Kaposi Sarcoma Market Size by Country
6.4.1 North America Kaposi Sarcoma Market Size by Country (2016-2021)
6.4.2 North America Kaposi Sarcoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Kaposi Sarcoma Market Size (2016-2027)
7.2 Europe Kaposi Sarcoma Market Size by Type
7.2.1 Europe Kaposi Sarcoma Market Size by Type (2016-2021)
7.2.2 Europe Kaposi Sarcoma Market Size by Type (2022-2027)
7.2.3 Europe Kaposi Sarcoma Market Size by Type (2016-2027)
7.3 Europe Kaposi Sarcoma Market Size by Application
7.3.1 Europe Kaposi Sarcoma Market Size by Application (2016-2021)
7.3.2 Europe Kaposi Sarcoma Market Size by Application (2022-2027)
7.3.3 Europe Kaposi Sarcoma Market Size by Application (2016-2027)
7.4 Europe Kaposi Sarcoma Market Size by Country
7.4.1 Europe Kaposi Sarcoma Market Size by Country (2016-2021)
7.4.2 Europe Kaposi Sarcoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Kaposi Sarcoma Market Size (2016-2027)
8.2 Asia-Pacific Kaposi Sarcoma Market Size by Type
8.2.1 Asia-Pacific Kaposi Sarcoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kaposi Sarcoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kaposi Sarcoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Kaposi Sarcoma Market Size by Application
8.3.1 Asia-Pacific Kaposi Sarcoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kaposi Sarcoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kaposi Sarcoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Kaposi Sarcoma Market Size by Region
8.4.1 Asia-Pacific Kaposi Sarcoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kaposi Sarcoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Kaposi Sarcoma Market Size (2016-2027)
9.2 Latin America Kaposi Sarcoma Market Size by Type
9.2.1 Latin America Kaposi Sarcoma Market Size by Type (2016-2021)
9.2.2 Latin America Kaposi Sarcoma Market Size by Type (2022-2027)
9.2.3 Latin America Kaposi Sarcoma Market Size by Type (2016-2027)
9.3 Latin America Kaposi Sarcoma Market Size by Application
9.3.1 Latin America Kaposi Sarcoma Market Size by Application (2016-2021)
9.3.2 Latin America Kaposi Sarcoma Market Size by Application (2022-2027)
9.3.3 Latin America Kaposi Sarcoma Market Size by Application (2016-2027)
9.4 Latin America Kaposi Sarcoma Market Size by Country
9.4.1 Latin America Kaposi Sarcoma Market Size by Country (2016-2021)
9.4.2 Latin America Kaposi Sarcoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kaposi Sarcoma Market Size (2016-2027)
10.2 Middle East & Africa Kaposi Sarcoma Market Size by Type
10.2.1 Middle East & Africa Kaposi Sarcoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kaposi Sarcoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kaposi Sarcoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Kaposi Sarcoma Market Size by Application
10.3.1 Middle East & Africa Kaposi Sarcoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kaposi Sarcoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kaposi Sarcoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Kaposi Sarcoma Market Size by Country
10.4.1 Middle East & Africa Kaposi Sarcoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kaposi Sarcoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aphios
11.1.1 Aphios Company Details
11.1.2 Aphios Business Overview
11.1.3 Aphios Kaposi Sarcoma Introduction
11.1.4 Aphios Revenue in Kaposi Sarcoma Business (2016-2021)
11.1.5 Aphios Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Kaposi Sarcoma Introduction
11.2.4 Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2016-2021)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Cytori Therapeutics
11.3.1 Cytori Therapeutics Company Details
11.3.2 Cytori Therapeutics Business Overview
11.3.3 Cytori Therapeutics Kaposi Sarcoma Introduction
11.3.4 Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2016-2021)
11.3.5 Cytori Therapeutics Recent Development
11.4 CytRx
11.4.1 CytRx Company Details
11.4.2 CytRx Business Overview
11.4.3 CytRx Kaposi Sarcoma Introduction
11.4.4 CytRx Revenue in Kaposi Sarcoma Business (2016-2021)
11.4.5 CytRx Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Kaposi Sarcoma Introduction
11.5.4 Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Kaposi Sarcoma Introduction
11.6.4 GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Kaposi Sarcoma Introduction
11.7.4 Roche Revenue in Kaposi Sarcoma Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Kaposi Sarcoma Introduction
11.8.4 Johnson and Johnson Revenue in Kaposi Sarcoma Business (2016-2021)
11.8.5 Johnson and Johnson Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Kaposi Sarcoma Introduction
11.9.4 Merck Revenue in Kaposi Sarcoma Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Kaposi Sarcoma Introduction
11.10.4 Pfizer Revenue in Kaposi Sarcoma Business (2016-2021)
11.10.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Kaposi Sarcoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Classic
Table 3. Key Players of Endemic
Table 4. Key Players of Immunosuppresion Therapy-Related
Table 5. Key Players of Epidemic
Table 6. Global Kaposi Sarcoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Kaposi Sarcoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Kaposi Sarcoma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Kaposi Sarcoma Market Share by Regions (2016-2021)
Table 10. Global Kaposi Sarcoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Kaposi Sarcoma Market Share by Regions (2022-2027)
Table 12. Kaposi Sarcoma Market Trends
Table 13. Kaposi Sarcoma Market Drivers
Table 14. Kaposi Sarcoma Market Challenges
Table 15. Kaposi Sarcoma Market Restraints
Table 16. Global Kaposi Sarcoma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Kaposi Sarcoma Market Share by Players (2016-2021)
Table 18. Global Top Kaposi Sarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma as of 2020)
Table 19. Ranking of Global Top Kaposi Sarcoma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Kaposi Sarcoma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kaposi Sarcoma Product Solution and Service
Table 23. Date of Enter into Kaposi Sarcoma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Kaposi Sarcoma Revenue Market Share by Type (2016-2021)
Table 27. Global Kaposi Sarcoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Kaposi Sarcoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Kaposi Sarcoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Kaposi Sarcoma Revenue Market Share by Application (2016-2021)
Table 31. Global Kaposi Sarcoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Kaposi Sarcoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Kaposi Sarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Kaposi Sarcoma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Kaposi Sarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Kaposi Sarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Kaposi Sarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Kaposi Sarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Kaposi Sarcoma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Kaposi Sarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Kaposi Sarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Kaposi Sarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Kaposi Sarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Kaposi Sarcoma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Kaposi Sarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Kaposi Sarcoma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Kaposi Sarcoma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Kaposi Sarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Kaposi Sarcoma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Kaposi Sarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Kaposi Sarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Kaposi Sarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Kaposi Sarcoma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Kaposi Sarcoma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Kaposi Sarcoma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Kaposi Sarcoma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Kaposi Sarcoma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Kaposi Sarcoma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Aphios Company Details
Table 64. Aphios Business Overview
Table 65. Aphios Kaposi Sarcoma Product
Table 66. Aphios Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 67. Aphios Recent Development
Table 68. Bristol Myers Squibb Company Details
Table 69. Bristol Myers Squibb Business Overview
Table 70. Bristol Myers Squibb Kaposi Sarcoma Product
Table 71. Bristol Myers Squibb Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 72. Bristol Myers Squibb Recent Development
Table 73. Cytori Therapeutics Company Details
Table 74. Cytori Therapeutics Business Overview
Table 75. Cytori Therapeutics Kaposi Sarcoma Product
Table 76. Cytori Therapeutics Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 77. Cytori Therapeutics Recent Development
Table 78. CytRx Company Details
Table 79. CytRx Business Overview
Table 80. CytRx Kaposi Sarcoma Product
Table 81. CytRx Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 82. CytRx Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Kaposi Sarcoma Product
Table 86. Eli Lilly and Company Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Kaposi Sarcoma Product
Table 91. GlaxoSmithKline Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Kaposi Sarcoma Product
Table 96. Roche Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. Johnson and Johnson Company Details
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 101. Johnson and Johnson Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Kaposi Sarcoma Product
Table 105. Merck Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Kaposi Sarcoma Product
Table 110. Pfizer Revenue in Kaposi Sarcoma Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kaposi Sarcoma Market Share by Type: 2020 VS 2027
Figure 2. Classic Features
Figure 3. Endemic Features
Figure 4. Immunosuppresion Therapy-Related Features
Figure 5. Epidemic Features
Figure 6. Global Kaposi Sarcoma Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Cancer Research Institution Case Studies
Figure 9. Clinics Case Studies
Figure 10. Kaposi Sarcoma Report Years Considered
Figure 11. Global Kaposi Sarcoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Kaposi Sarcoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Kaposi Sarcoma Market Share by Regions: 2020 VS 2027
Figure 14. Global Kaposi Sarcoma Market Share by Regions (2022-2027)
Figure 15. Global Kaposi Sarcoma Market Share by Players in 2020
Figure 16. Global Top Kaposi Sarcoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kaposi Sarcoma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Kaposi Sarcoma Revenue in 2020
Figure 18. Global Kaposi Sarcoma Revenue Market Share by Type (2016-2021)
Figure 19. Global Kaposi Sarcoma Revenue Market Share by Type (2022-2027)
Figure 20. North America Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Kaposi Sarcoma Market Share by Type (2016-2027)
Figure 22. North America Kaposi Sarcoma Market Share by Application (2016-2027)
Figure 23. North America Kaposi Sarcoma Market Share by Country (2016-2027)
Figure 24. United States Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Kaposi Sarcoma Market Share by Type (2016-2027)
Figure 28. Europe Kaposi Sarcoma Market Share by Application (2016-2027)
Figure 29. Europe Kaposi Sarcoma Market Share by Country (2016-2027)
Figure 30. Germany Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Kaposi Sarcoma Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Kaposi Sarcoma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Kaposi Sarcoma Market Share by Region (2016-2027)
Figure 40. China Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Kaposi Sarcoma Market Share by Type (2016-2027)
Figure 48. Latin America Kaposi Sarcoma Market Share by Application (2016-2027)
Figure 49. Latin America Kaposi Sarcoma Market Share by Country (2016-2027)
Figure 50. Mexico Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Kaposi Sarcoma Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Kaposi Sarcoma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Kaposi Sarcoma Market Share by Country (2016-2027)
Figure 56. Turkey Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Kaposi Sarcoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Aphios Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 61. Cytori Therapeutics Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 62. CytRx Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 66. Johnson and Johnson Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Kaposi Sarcoma Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のユーイング肉腫治療薬市場規模・現状・予測（2021年-2027年） Ewing sarcoma is a cancerous tumor that grows in the bones or in the tissue around bones (soft tissue)—often the legs, pelvis, ribs, arms or spine. Ewing sarcoma can spread to the lungs, bones and bone marrow. Market Analysis and Insights: Global Ewing Sarcoma Drugs Market The global Ewing Sarcoma D…- 世界の軟部肉腫治療市場規模・現状・予測（2021年-2027年） Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market. Market Analysis and Insights: Global So…
- 世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の糖尿病及び関連疾患用幹細胞療法市場規模・現状・予測（2021年-2027年） Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). NSI-566 is the stem cell thera…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …